Page last updated: 2024-10-22

amitriptyline and Disruptive, Impulse Control, and Conduct Disorders

amitriptyline has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fishbain, DA1

Other Studies

1 other study available for amitriptyline and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Kleptomanic behavior response to perphenazine-amitriptyline HCL combination.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1988, Volume: 33, Issue:3

    Topics: Amitriptyline; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female

1988